ARV defaults may derail Botswana’s UNAIDS 90-90-90 targets

Botswana’s HIV Progress At Risk Amidst ARV Shortages

Botswana’s acclaimed fight against HIV/AIDS faces a significant challenge. Reports indicate a scarcity of crucial antiretroviral (ARV) medications, a situation that could jeopardize the nation’s long-standing achievements in combating the epidemic.

Impact on Global Targets

This shortage raises concerns about Botswana’s ability to meet the UNAIDS 90-90-90 targets. These ambitious goals aim for 90% of people living with HIV to know their status, 90% of those diagnosed to receive treatment, and 90% of those on treatment to achieve viral suppression. Originally envisioned as a pathway to ending the HIV epidemic, these benchmarks are now at risk.

A Model Program Under Threat

Botswana has historically been recognized for its effective HIV response. However, the current ARV supply issues threaten to undermine this progress. The potential disruption to treatment could have far-reaching consequences for public health in the country.